Blog
-
Blog
Massachusetts Biotech Community Calls on Congress to Fix the Small Molecule Penalty
05.22.2023
Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the attached letter.
-
Blog
From Bad to Worse on Drug Price Controls
05.18.2023
The life sciences venture capital community has long warned against the adverse consequences government price controls for prescription drugs would...
-
Blog
Incubate Celebrates World IP Day
04.26.2023
In the world of Making Medicine, every day should be World IP Day.
-
Blog
Incubate Takes the Stand: Testifying on Global Importance of IP
03.30.2023
See Incubate's blog post from Executive Director John Stanford on his recent testimony before the International Trade Organization about how weakening Intellectual Property protections will damage the early-stage life science ecosystem.
-
Blog
Mergers and Acquisitions: A Key Driver of VC Investment in Healthcare
02.18.2021
The drug pricing debate is a worthy one. We have to have open discussions about maximizing innovation and access. But half-written reports from a region that is home to the economic benefits of this industry do little to move that debate forward.